Kurs Kun Run Biotechnology, Inc.

Aktien

17.06.10	KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration
22.04.10	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement
30.03.10	KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results
13.11.09	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
30.11.-1	KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	% 1 Jahr	Veränd. 3 Jahre	Kap.($)
KUN RUN BIOTECHNOLOGY, INC.	-.--%	-.--%	-	-	0
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.24%	+0.93%	+19.83%	+71.67%	48.37 Mrd.
OTSUKA HOLDINGS CO., LTD.	+1.12%	+1.41%	+54.88%	+122.68%	39.88 Mrd.
CIPLA LIMITED	-1.13%	-1.14%	-11.01%	+14.39%	12.05 Mrd.
ZYDUS LIFESCIENCES LIMITED	+1.61%	+3.55%	+15.78%	+80.31%	11.77 Mrd.
KRKA, D. D.	+0.19%	0.00%	+30.98%	+150.00%	9.19 Mrd.
GEDEON RICHTER	-0.67%	+3.34%	+24.63%	+45.46%	7.87 Mrd.
ONO PHARMACEUTICAL CO., LTD.	+1.30%	+1.26%	+54.43%	-10.73%	7.25 Mrd.
GLENMARK PHARMACEUTICALS LIMITED	+1.83%	+8.82%	+25.32%	+218.66%	7.1 Mrd.
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+0.95%	-8.22%	-39.88%	+16.67%	5.26 Mrd.
Durchschnitt	+0.54%	+0.69%	+19.44%	+78.79%	16.53 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung	+0.45%	+1.17%	+27.19%	+85.90%